NCT06654245

Brief Summary

This clinical trial evaluates whether a shared response plan (SHAREDCare) improves follow-up care for lung cancer survivors. As the number of cancer survivors increases, there is a new need for high-quality chronic illness care. High-quality chronic illness care can be difficult to deliver and involves working with the patient to be certain they have what they need to be actively involved with their care to meet their needs. SHAREDCare allows the patient to work with a navigator to review identified distress and social needs. The patient and navigator discuss the needs and develop a shared response plan to address the needs in ways that consider the patient's current behaviors, beliefs, and motivation. The plan also establishes specific patient goals, anticipates barriers, and establishes how the navigator will follow-up on the needs and adjust care and assistance when needed. Using a shared response plan may improve follow-up care for lung cancer survivors.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
5

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 21, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

October 23, 2024

Completed
8 months until next milestone

Study Start

First participant enrolled

June 11, 2025

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 12, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 12, 2026

Completed
Last Updated

January 30, 2026

Status Verified

January 1, 2026

Enrollment Period

7 months

First QC Date

October 21, 2024

Last Update Submit

January 28, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • SHAREDCare's Qualitative Acceptability

    Will be assessed with semi-structured interviews. These methods will be guided by Grounded Theory, a process using inductive coding to develop theory from data (e.g., themes relating to components, timing, or delivery of the intervention).

    At 4 weeks post-initial call

Secondary Outcomes (9)

  • SHAREDCare's Quantitative Acceptability

    At 4 weeks post-initial call

  • SHAREDCare's Quantitative Appropriateness

    At 4 weeks post-initial call

  • SHAREDCare's Quantitative Feasibility

    At 4 weeks post-initial call

  • Number of Survivors With Unmet Needs

    At baseline and at 4 weeks post-initial call

  • Number of Clinical Referrals Made

    At 4 weeks post-initial call

  • +4 more secondary outcomes

Study Arms (1)

SHAREDCare Supportive care arm

EXPERIMENTAL

Patients receive a SHAREDCare call with a navigator to discuss identified distress and social needs and develop/deploy a shared response plan to address identified needs on study. Patients also receive standard of care automated referrals on study. Two weeks following the initial call, patients receive a second SHAREDCare call with a navigator to follow-up on the shared response plan.

Behavioral: Telephone based interviewOther: Survey using a questionnaire.Other: Electronic health record reviewOther: Referral

Interventions

Receive SHAREDCare navigator calls

SHAREDCare Supportive care arm

Ancillary studies

SHAREDCare Supportive care arm

Ancillary studies

SHAREDCare Supportive care arm

Receive standard of care automated referrals

SHAREDCare Supportive care arm

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must have histologically or cytologically confirmed study disease. A pathology report should be referenced/available (stages I-IV lung cancer)
  • Ability to understand and the willingness to sign an institutional review board (IRB)-approved informed consent document
  • ≥ 18 years of age
  • Within two years of lung cancer diagnosis
  • Able to understand, read and write English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atrium Health Wake Forest Baptist Comprehensive Cancer Center (AH-WFBCCC)

Winston-Salem, North Carolina, 27157, United States

Location

MeSH Terms

Conditions

Lung Neoplasms

Interventions

Referral and Consultation

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services Administration

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 21, 2024

First Posted

October 23, 2024

Study Start

June 11, 2025

Primary Completion

January 12, 2026

Study Completion

January 12, 2026

Last Updated

January 30, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations